Susan Fox

493 total citations
11 papers, 226 citations indexed

About

Susan Fox is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Susan Fox has authored 11 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Susan Fox's work include Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Susan Fox is often cited by papers focused on Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Susan Fox collaborates with scholars based in United States, Canada and United Kingdom. Susan Fox's co-authors include Bruce J. Roth, Charalambos Andreadis, David A. Rizzieri, Amanda Copeland, Michael Crump, Anas Younes, Richard C. Chao, Diane Potvin, Mary Collins and Sarit Assouline and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Susan Fox

11 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Fox United States	7	102	84	77	44	41	11	226
S S Banerjee United Kingdom	8	57 0.6×	39 0.5×	62 0.8×	32 0.7×	37 0.9×	9	155
Marek Kania United States	8	56 0.5×	52 0.6×	119 1.5×	66 1.5×	21 0.5×	26	196
Gairin Dancey United Kingdom	6	86 0.8×	43 0.5×	58 0.8×	43 1.0×	18 0.4×	9	227
Jingfeng Lu China	11	32 0.3×	214 2.5×	71 0.9×	47 1.1×	23 0.6×	16	319
F. Zumaglini Italy	6	62 0.6×	24 0.3×	61 0.8×	41 0.9×	10 0.2×	13	160
Joseph G. Schroers‐Martin United States	6	97 1.0×	60 0.7×	99 1.3×	75 1.7×	80 2.0×	26	283
Michele Babicky United States	7	109 1.1×	72 0.9×	75 1.0×	28 0.6×	16 0.4×	14	257
Joon Young Hur South Korea	10	28 0.3×	54 0.6×	238 3.1×	84 1.9×	49 1.2×	26	346
Jean-Pierre Lotz France	4	143 1.4×	38 0.5×	61 0.8×	39 0.9×	6 0.1×	5	229
Benjamin Garmezy United States	8	48 0.5×	68 0.8×	84 1.1×	63 1.4×	27 0.7×	35	211

Countries citing papers authored by Susan Fox

Since Specialization

Citations

This map shows the geographic impact of Susan Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Fox more than expected).

Fields of papers citing papers by Susan Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Fox. The network helps show where Susan Fox may publish in the future.

Co-authorship network of co-authors of Susan Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Fox. A scholar is included among the top collaborators of Susan Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Fox. Susan Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sperlich, Catherine, et al.. (2022). Refractory immune TTP following Pfizer‐BioNTech COVID‐19 vaccine successfully salvaged with caplacizumab. Journal of Thrombosis and Haemostasis. 20(7). 1696–1698. 2 indexed citations

Batlevi, Connie Lee, Michael Crump, Charalambos Andreadis, et al.. (2017). A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. British Journal of Haematology. 178(3). 434–441. 80 indexed citations

Crump, Michael, Charalambos Andreadis, Sarit Assouline, et al.. (2013). A phase II study of single agent mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in patients with diffuse large cell B-cell (DLBCL) and follicular (FL) lymphomas.. Journal of Clinical Oncology. 31(15_suppl). 8535–8535. 4 indexed citations

Hirsh, Vera, Jean Latreille, Harvey Kreisman, et al.. (2005). Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities—a multicenter phase II trial. Lung Cancer. 49(1). 117–123. 8 indexed citations

Sweeney, Christopher J., David Finch, Richard Bihrle, et al.. (1999). A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium. Cancer. 86(3). 514–518. 52 indexed citations

Sandler, Alan, Susan Fox, George Weber, et al.. (1998). Paclitaxel Plus Gallium Nitrate and Filgrastim in Patients With Refractory Malignancies. American Journal of Clinical Oncology. 21(2). 180–184. 8 indexed citations

Sandler, Alan B., et al.. (1998). A Phase II Trial of Paclitaxel in Refractory Germ Cell Tumors. The Journal of Urology. 160(6 Part 1). 2293–2294. 5 indexed citations

Sandler, Alan B., et al.. (1998). A phase II trial of paclitaxel in refractory germ cell tumors. Cancer. 82(7). 1381–1386. 37 indexed citations

Sandler, Alan N., Derek Raghavan, Neal J. Meropol, et al.. (1997). A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors. European Journal of Cancer. 33. S248–S248. 19 indexed citations

10.

Fox, Susan, et al.. (1993). Testicular cancer. Seminars in Oncology Nursing. 9(4). 224–236. 2 indexed citations

11.

Fox, Susan & R. D. Gillard. (1988). Mixed neutral compounds of palladium(II) and platinum (II) chelated by diolato(2−) and di-imine ligands. Polyhedron. 7(5). 349–352. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact